These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 37894344)

  • 41. Tumor associated macrophages-derived exosomes facilitate hepatocellular carcinoma malignance by transferring lncMMPA to tumor cells and activating glycolysis pathway.
    Xu M; Zhou C; Weng J; Chen Z; Zhou Q; Gao J; Shi G; Ke A; Ren N; Sun H; Shen Y
    J Exp Clin Cancer Res; 2022 Aug; 41(1):253. PubMed ID: 35986343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Manipulation of the tumor immuno-microenvironment via TAM-targeted expression of transcription factors.
    Musick M; Yu X
    Immunol Res; 2022 Aug; 70(4):432-440. PubMed ID: 35486115
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T cell-mediated targeted delivery of tadalafil regulates immunosuppression and polyamine metabolism to overcome immune checkpoint blockade resistance in hepatocellular carcinoma.
    Wang X; Zhang Q; Zhou J; Xiao Z; Liu J; Deng S; Hong X; Huang W; Cai M; Guo Y; Huang J; Wang Y; Lin L; Zhu K
    J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36813307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolic reprograming of tumor-associated macrophages.
    Puthenveetil A; Dubey S
    Ann Transl Med; 2020 Aug; 8(16):1030. PubMed ID: 32953830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Topological analysis of hepatocellular carcinoma tumour microenvironment based on imaging mass cytometry reveals cellular neighbourhood regulated reversely by macrophages with different ontogeny.
    Sheng J; Zhang J; Wang L; Tano V; Tang J; Wang X; Wu J; Song J; Zhao Y; Rong J; Cheng F; Wang J; Shen Y; Wen L; He J; Zhang H; Li T; Zhang Q; Bai X; Lu Z; Liang T
    Gut; 2022 Jun; 71(6):1176-1191. PubMed ID: 34253573
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of tumor-associated macrophages in the progression of hepatocellular carcinoma.
    Shirabe K; Mano Y; Muto J; Matono R; Motomura T; Toshima T; Takeishi K; Uchiyama H; Yoshizumi T; Taketomi A; Morita M; Tsujitani S; Sakaguchi Y; Maehara Y
    Surg Today; 2012 Jan; 42(1):1-7. PubMed ID: 22116397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel insight into cancer therapy: Lipid metabolism in tumor-associated macrophages.
    Ren Y; Wang M; Yuan H; Wang Z; Yu L
    Int Immunopharmacol; 2024 Jun; 135():112319. PubMed ID: 38801810
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour-associated macrophages heterogeneity drives resistance to clinical therapy.
    Guo S; Chen X; Guo C; Wang W
    Expert Rev Mol Med; 2022 Apr; 24():e17. PubMed ID: 35400355
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.
    Wang Y; Wang B; Xiao S; Li Y; Chen Q
    J Cell Biochem; 2019 Mar; 120(3):3046-3055. PubMed ID: 30536969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reprogramming tumor-associated macrophages as a unique approach to target tumor immunotherapy.
    Khan SU; Khan MU; Azhar Ud Din M; Khan IM; Khan MI; Bungau S; Hassan SSU
    Front Immunol; 2023; 14():1166487. PubMed ID: 37138860
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.
    Sun G; Liu H; Zhao J; Zhang J; Huang T; Sun G; Zhao S; Zhang Z; Cao H; Rong D; Kong X; Ji Q; Liu L; Wang X; Tang W; Xia Y
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting tumor-associated macrophages in the tumor microenvironment.
    Zhou K; Cheng T; Zhan J; Peng X; Zhang Y; Wen J; Chen X; Ying M
    Oncol Lett; 2020 Nov; 20(5):234. PubMed ID: 32968456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A theranostic metallodrug modulates immunovascular crosstalk to combat immunosuppressive liver cancer.
    Luo Y; Wang J; Xu L; Du Q; Fang N; Wu H; Liu F; Hu L; Xu J; Hou J; Zhong Y; Liu Y; Wang Z; Ran H; Guo D
    Acta Biomater; 2022 Dec; 154():478-496. PubMed ID: 36280029
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Li C; Pan XY; Ma M; Zhao J; Zhao F; Lv YP
    Pharm Biol; 2021 Dec; 59(1):1533-1539. PubMed ID: 34726570
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Targeting tumor-associated macrophages: Novel insights into immunotherapy of skin cancer.
    Liu J; Lu J; Wu L; Zhang T; Wu J; Li L; Tai Z; Chen Z; Zhu Q
    J Adv Res; 2024 Jan; ():. PubMed ID: 38242529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.
    Yang Y; Ye YC; Chen Y; Zhao JL; Gao CC; Han H; Liu WC; Qin HY
    Cell Death Dis; 2018 Jul; 9(8):793. PubMed ID: 30022048
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Individualized precision treatment: Targeting TAM in HCC.
    Li Z; Wu T; Zheng B; Chen L
    Cancer Lett; 2019 Aug; 458():86-91. PubMed ID: 31129147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autophagy drives plasticity and functional polarization of tumor-associated macrophages.
    Kuo WT; Chang JM; Chen CC; Tsao N; Chang CP
    IUBMB Life; 2022 Feb; 74(2):157-169. PubMed ID: 34467634
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nanomedicine-based cancer immunotherapies developed by reprogramming tumor-associated macrophages.
    Li X; Guo X; Ling J; Tang Z; Huang G; He L; Chen T
    Nanoscale; 2021 Mar; 13(9):4705-4727. PubMed ID: 33625411
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reprogramming of tumor-associated macrophages by metabolites generated from tumor microenvironment.
    Kim SW; Kim CW; Moon YA; Kim HS
    Anim Cells Syst (Seoul); 2024; 28(1):123-136. PubMed ID: 38577621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.